Treatment of Genetic Screening of Hypertriglyceridemia type I, III, and V - HTG Amsterdam

ABSTRACT:

This is a cohort of patients with extreme hypertriglyceridemia. Patients have been screened for loss of function mutations in LPL, GPIHBP1, APOC2, APOA5 and LMF1.

PROVIDER: phs000511 | dbGaP |

SECONDARY ACCESSION(S): PRJNA170224PRJNA170225

REPOSITORIES: dbGaP